These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30172723)

  • 1. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
    Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
    Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
    Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
    Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
    Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
    [No Abstract]   [Full Text] [Related]  

  • 5. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
    Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
    Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
    Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of immunomodulatory mediators in oral precancerous lesions.
    Gonçalves AS; Mosconi C; Jaeger F; Wastowski IJ; Aguiar MCF; Silva TA; Ribeiro-Rotta RF; Costa NL; Batista AC
    Hum Immunol; 2017 Nov; 78(11-12):752-757. PubMed ID: 28941745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
    Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
    Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
    Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
    Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.
    Wu X; Cao W; Wang X; Zhang J; Lv Z; Qin X; Wu Y; Chen W
    Mol Cancer; 2013 Dec; 12(1):151. PubMed ID: 24289313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.
    Wang X; Jin Y; Li YX; Yang Y
    Oncol Rep; 2018 Apr; 39(4):1793-1804. PubMed ID: 29436667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
    Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
    Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
    Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
    J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer.
    Webber LP; Wagner VP; Curra M; Vargas PA; Meurer L; Carrard VC; Squarize CH; Castilho RM; Martins MD
    Histopathology; 2017 Aug; 71(2):278-286. PubMed ID: 28326594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
    Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
    Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.